FREGONA, DOLORES
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.350
AS - Asia 11.119
EU - Europa 4.925
SA - Sud America 1.868
AF - Africa 1.749
OC - Oceania 193
Continente sconosciuto - Info sul continente non disponibili 82
Totale 39.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.331
SG - Singapore 3.823
CN - Cina 1.939
VN - Vietnam 1.452
HK - Hong Kong 1.193
BR - Brasile 1.121
IT - Italia 617
FI - Finlandia 530
DE - Germania 452
FR - Francia 451
PL - Polonia 367
SE - Svezia 340
IN - India 339
UA - Ucraina 305
BD - Bangladesh 295
GB - Regno Unito 252
IQ - Iraq 201
RU - Federazione Russa 160
AR - Argentina 155
TR - Turchia 155
NL - Olanda 144
CA - Canada 124
CO - Colombia 113
MX - Messico 108
ID - Indonesia 106
ES - Italia 105
PK - Pakistan 104
EC - Ecuador 103
PH - Filippine 100
SA - Arabia Saudita 98
JP - Giappone 96
IE - Irlanda 92
ZA - Sudafrica 91
UZ - Uzbekistan 79
TN - Tunisia 73
MA - Marocco 72
AU - Australia 71
TH - Thailandia 71
BJ - Benin 69
DZ - Algeria 67
EG - Egitto 66
PE - Perù 66
VE - Venezuela 65
JO - Giordania 64
KE - Kenya 64
JM - Giamaica 63
KZ - Kazakistan 59
PY - Paraguay 59
MY - Malesia 57
PS - Palestinian Territory 55
AZ - Azerbaigian 54
ET - Etiopia 54
GR - Grecia 54
HN - Honduras 54
NP - Nepal 54
CR - Costa Rica 53
AL - Albania 52
BO - Bolivia 52
BZ - Belize 52
RO - Romania 52
UY - Uruguay 51
BE - Belgio 50
AE - Emirati Arabi Uniti 49
CL - Cile 49
CV - Capo Verde 49
TW - Taiwan 49
LV - Lettonia 48
CZ - Repubblica Ceca 47
KG - Kirghizistan 47
PT - Portogallo 47
CW - ???statistics.table.value.countryCode.CW??? 46
GN - Guinea 46
HU - Ungheria 46
LY - Libia 46
TT - Trinidad e Tobago 46
AO - Angola 45
GT - Guatemala 45
IL - Israele 45
CH - Svizzera 44
LB - Libano 44
MD - Moldavia 44
PR - Porto Rico 44
RS - Serbia 44
SN - Senegal 44
BB - Barbados 43
LC - Santa Lucia 43
MN - Mongolia 43
AM - Armenia 42
BY - Bielorussia 42
CM - Camerun 42
HR - Croazia 42
KR - Corea 42
BS - Bahamas 41
GA - Gabon 41
NO - Norvegia 41
ZW - Zimbabwe 41
CG - Congo 40
GE - Georgia 40
LU - Lussemburgo 40
MG - Madagascar 40
Totale 37.291
Salva come PNG Salva come JPEG
Città #
Singapore 2.347
San Jose 1.944
Woodbridge 1.721
Ashburn 1.697
Fairfield 1.492
Ann Arbor 1.366
Hong Kong 1.081
Houston 983
Jacksonville 937
Chandler 862
Wilmington 697
Santa Clara 580
Seattle 561
Cambridge 517
Ho Chi Minh City 431
Boardman 380
Beijing 355
Princeton 347
Hanoi 322
Bytom 302
Los Angeles 282
Lauterbourg 226
Helsinki 220
Medford 184
Nanjing 171
San Diego 145
New York 143
Des Moines 131
Padova 126
Roxbury 101
Buffalo 96
São Paulo 94
Baghdad 93
Guangzhou 86
Munich 78
Da Nang 72
Tashkent 68
Chicago 67
Dublin 67
Cotonou 66
Orem 60
Amman 59
Haiphong 59
Hebei 57
Nairobi 56
Tokyo 54
Baku 52
London 52
Shenyang 51
Nanchang 50
Norwalk 49
Chennai 45
Conakry 45
Turku 45
Changsha 44
Dong Ket 44
Johannesburg 44
Porto Alegre 43
Castries 42
Dakar 42
Istanbul 42
Riga 42
Rio de Janeiro 42
Ulan Bator 42
Montevideo 41
Praia 41
Addis Ababa 40
Managua 40
San José 40
Bishkek 39
Bridgetown 39
Dallas 39
Harare 39
Kingston 39
Warsaw 39
Frankfurt am Main 38
Jiaxing 38
Kampala 38
Libreville 38
Nassau 38
Willemstad 38
Hải Dương 37
Lima 37
Rome 37
Phoenix 36
Andorra la Vella 35
Antananarivo 35
Bamako 35
Panama City 35
Quito 35
Hefei 34
Nouakchott 34
Lahore 33
Luanda 33
Niamey 33
Podgorica 33
Abidjan 32
Brooklyn 32
Dushanbe 32
Jeddah 32
Totale 23.913
Salva come PNG Salva come JPEG
Nome #
CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy. 348
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway 303
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 281
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 274
Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3α/β and Bax, leading to permeability transition pore opening and tumor cell death 264
Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts 263
Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties 260
Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity 259
Gold complexes for therapeutic purposes: An updated Patent review (2010-2015) 254
Gold(III) Complexes in the Oncological Preclinical Arena: from Aminoderivatives to Peptidomimetics 249
Erythrocyte aminolevulinic acid dehydratase inhibition by cis-platin 248
Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: Loading into nanocarriers and preliminary biological studies 246
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 243
Promising Anticancer Mono- and Dinuclear Ruthenium(III) Dithiocarbamato Complexes: Systematic Solution Studies 239
Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology? 239
Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties and in vitro antitumor activity 238
Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents 238
Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations 238
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts 236
Renal proximal tubule segment-specific nephrotoxicity: An overview on biomarkers and histopathology 232
Characterization studies and cytotoxicity assays of Pt(II) and Pd(II) dithiocarbamate complexes by means of FT-IR, NMR spectroscopy and mass spectrometry 232
Gold(III) dithiocarbamate derivatives for the treatment of cancer: Solution chemistry, DNA binding, and hemolytic properties 228
Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancerchemotherapy 227
Ruthenium(II/III)-based Compounds with Encouraging Antiproliferative Activity against Non-Small Cell Lung Cancer 226
Gold(III)-dithiocarbamato anticancer agents: activity, toxicology and histopathological studies in rodents 225
CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics 223
Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agents 222
Insights into the Reactivity of Gold-Dithiocarbamato Anticancer Agents toward Model Biomolecules by Using Multinuclear NMR Spectroscopy 220
Synthesis, characterization and in vitro cytotoxicity of new organotin(IV) derivatives of N-methylglycine 217
Preliminary chemico-biological studies on Ru(III) compounds with S-methyl pyrrolidine/dimethyl dithiocarbamate 217
Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity 216
Zinc(II) Complexes with Dithiocarbamato Derivatives: Structural Characterization and Biological Assays on Cancerous Cell Lines 216
Gold(III) dithiocarbamate derivatives of N- methylglycine: an experimental and theoretical investigation 214
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Ru, Ga) 214
Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity 210
Gold(III) complexes sensitize mitochondria of tumor cells to permeability transition. 210
Synthesis of a palladium(II)-dithiocarbamate complex: biological assay and nephrotoxicity in rats 207
Gold complexes as prospective metal-based anticancer drugs 206
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Au, Cu) 206
Antiproliferative and Apoptotic Effects of Two New Pd(II)Methylsarcosinedithiocarbamate Derivatives on Human Acute Myeloid Leukemia Cells In Vitro 204
Functionalized dithioester and dithiocarbamato complexes of platinum(II) halides 204
Mitochondrial toxicity in vitro induced by gold(III)-complexes 204
Noble metal-dithiocarbamates: precious allies in the fight against cancer 204
Structural Characterization of a Gold/Serum Albumin Complex 204
Palladium and platinum complexes with N,N-dimethylselenourea 203
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 203
Chemical and biological profiles of novel copper(II) complexes containing s-donor ligands for the treatment of cancer 201
Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics 201
t-Butylsarcosinedithiocarbamato gold(III)-based anticancer agents: design, in vitro biological evaluation and interaction with model biomolecules 200
Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future. 197
Conductive Cu-TiO2 thin films obtained via MOCVD 196
Gold(III) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents 196
Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes 195
GOLD (III) COMPLEXES WITH OLIGOPEPTIDES FUNCTIONALIZED WITH SULFUR DONORS AND USE THEREOF AS ANTITUMOR AGENTS 194
Antitumor activity of gold(III) dithiocarbamato-peptide in prostate cancer cells and xenografts 192
Recent advances in PUVA photochemotherapy and PDT for the treatment of cancer 192
Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy 191
SYNTHESIS, CHARACTERIZATION AND CRYSTAL-STRUCTURE OF 2-DIMETHYLACETAL-4-CHLORO-6-FORMYLPHENOL AND AQUABIS(2-DIMETHYLACETAL-4-CHLORO-6-FORMYLPHENOLATO)-DIOXOURANIUM(VI) 189
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia 189
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts 187
Citotoxicity and DNA damage induced by a new platinum(II) complex with pyridine and dithiocarbamate. 184
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 183
Antiproliferative and apoptotic effects of two new gold(III) methylsarcosinedithiocarbamate derivatives on human acute myeloid leucemia cells in vitro 182
TIN AND GERMANIUM COMPLEXES WITH MALTOL 181
ORGANOTIN COMPLEXES OF 4-PYRONES 180
Beyond Platinums: Gold Complexes as Anticancer Agents 180
Synthesis of a new platinum(II)complex: anticancer activity and nephrotoxicity in vitro 179
Renal Effects of gold(III)-dithiocarbamate complex 176
Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents 175
Ru(III) potential antitumoral agents with sulfur chelating ligands 174
Latest insights into the anticancer activity of gold(III)-dithiocarbamato complexes 172
LANTHANIDE(III) COMPLEXES WITH CONDENSATION PRECURSORS 170
Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterisation and cell assay 170
Gold(III) dithiocarbamate derivatives as potential antitumor agents: synthesis, characterization, solution chemistry and cytotoxic properties 169
SYNTHESIS AND CHARACTERIZATION OF URANYL(VI) AND THORIUM(IV) COMPLEXES WITH PHOSPHINE OXIDES - THE CRYSTAL-STRUCTURE OF UO2(NO3)2(NO2-C6H4PH2PO)2 168
PALLADIUM-DIHALIDE COMPLEXES WITH CARBONYL DONORS 168
Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future. 168
INTERACTION OF SELENOUREAS WITH TIN AND GERMANIUM DERIVATIVES 167
Antitumor activity and nephrotoxicity of a new platinum(II) complex with pyridine and dithiocarbamate 165
Groundbreaking gold(III) anticancer agents 165
Bioconjugation of dithiocarbamato complexes to purine substrates for the treatment and diagnosis of colorectal cancer 164
DIOXOURANIUM(VI) COMPLEXES WITH 2,6-DIFORMYL-4-CHLOROPHENOL 164
Gold(III)-dithiocarbamato complexes induce cancer cell death triggered by thioredoxin redox system inhibition and activation of ERK pathway 164
Palladium and platinum dithiocarbamato compexes containing mono- and diamines. 163
Uranyl(VI), copper(II) and nickel(II) complexes derived from a new compartmental ligand 163
Complessi metallici di interesse biologico 163
Inhibition of tumor proteasome activity by gold dithiocarbamato complexes via both redox-dependent and -independent processes 162
DIOXOURANIUM(VI) COMPLEXES WITH FORMYLPHENOL DERIVATIVES 162
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 161
Crystal structure of bis(n-propylamine)dichloropalladium(II), (CH3CH2CH2NH2)2PdCl 2 159
LANTHANIDE COMPLEXES WITH MALTOL - THE CRYSTAL-STRUCTURE OF DIAQUATRIS(MALTOLATO)PRASEODYMIUM(III) TRIHYDRATE 159
An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015 159
Gold-based peptidomimetics for a targeted anticancer therapy 158
Innovative gold(III)-based anticancer drugs: chemico-biological studies to elucidate the mechanism of action 157
Interaction of organometallic derivatives of Sn(IV) with oxygen donor ligands 154
Conductive Cu-TiO2 thin films obtained via MOCVD 153
Cu(II) potential antitumor agents with sulfur chelating agents. 153
LANTHANIDE COMPLEXES OF 3-ACETYL-4-HYDROXY-6-METHYL-2H-PYRAN-2-ONE 153
Gold(III)- to Ruthenium(III)-metal exchange in dithiocarbmato complexes tunes their biological mode of action for cytotoxicity in cancer cells 152
DIOXOURANIUM(VI) COMPLEXES WITH POLYDENTATE SCHIFF-BASES CONTAINING ACETAL GROUPS 151
Totale 20.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.861
article - articoli 60.759
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 3.366
selected - selezionate 0
volume - volumi 540
Totale 173.526
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.508 80 472 269 217 79 138 110 213 94 41 268 527
2022/20232.119 478 111 13 196 415 316 1 143 306 7 97 36
2023/2024928 40 186 135 86 45 72 21 4 32 30 134 143
2024/20255.106 25 459 284 214 732 119 165 365 410 121 898 1.314
2025/202618.860 715 1.795 2.449 2.647 1.903 625 2.278 2.108 2.031 1.250 638 421
2026/2027408 408 0 0 0 0 0 0 0 0 0 0 0
Totale 39.418